Zepto partners with Orange Health to pilot in-app diagnostics in select cities
Zepto Diagnostics is powered by Orange Health and offers 60-minute sample collection and reports within six hours. The service is in beta and currently limited to Bengaluru, Delhi-NCR, Mumbai, and Hyderabad.
After collaborating with Amazon India, Orange Health Labs has now partnered with quick commerce platform Zepto to launch Zepto Diagnostics on its app.
The service, which is live in certain pincodes of Bengaluru, allows users to book a host of tests, including full-body checkups, thyroid, haemoglobin, etc. The service—from blood collection to report delivery—would be fully undertaken by Orange Health. The diagnostics platform promises 60-minute sample collection, from 6 am to 10 pm, and aims to deliver the report in under six hours. It is currently live in Bengaluru, Mumbai, Delhi-NCR, and Hyderabad.
Orange Health declined to comment on the development as the service is under beta testing. Zepto also did not immediately respond to queries shared by YourStory.
Quick diagnostics push
Earlier this year, Amazon India partnered with Orange Health to launch Amazon Diagnostics, an at-home diagnostics service that allows users to book lab tests, schedule and track appointments, and access digital reports from the Amazon app. The service went live in six cities and across 450 pincodes in June. The service allows users to book from over 800 diagnostic tests, promising doorstep sample collection and quick reports for routine tests.
Zepto had rolled out Zepto Pharmacy in August earlier this year in Mumbai, Hyderabad, Bengaluru, and Delhi. While over-the-counter drugs have been available on these platforms for some time, this expansion included prescription drugs, which require a valid doctor's prescription.
Similarly, Swiggy partnered with 360 One-backed PharmEasy in October last year to foray into pharmaceutical delivery. The partnership with the e-pharmacy company enabled Swiggy to skip over regulatory hurdles as it did not need fresh licenses and permits to comply with the Drugs and Cosmetics Rules, 1945.
Meanwhile, Blinkit earlier this year piloted the prescription medicines delivery service, complementing its existing OTC foray.
Edited by Kanishk Singh

